↓ Skip to main content

Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd006817.pub3
Pubmed ID
Authors

Tejasvi Chaudhari, William McGuire

Abstract

Delayed neuronal death following a perinatal hypoxic insult is due partly to xanthine oxidase-mediated production of cytotoxic free radicals. Evidence exists that allopurinol, a xanthine-oxidase inhibitor, reduces delayed cell death in experimental models of perinatal asphyxia and in people with organ reperfusion injury.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 1%
South Africa 1 1%
Unknown 84 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 17%
Student > Master 15 17%
Researcher 11 13%
Student > Ph. D. Student 10 12%
Student > Postgraduate 9 10%
Other 14 16%
Unknown 12 14%
Readers by discipline Count As %
Medicine and Dentistry 47 55%
Nursing and Health Professions 8 9%
Agricultural and Biological Sciences 3 3%
Arts and Humanities 2 2%
Social Sciences 2 2%
Other 5 6%
Unknown 19 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2012.
All research outputs
#1,749,229
of 13,751,259 outputs
Outputs from Cochrane database of systematic reviews
#4,492
of 10,737 outputs
Outputs of similar age
#15,752
of 122,128 outputs
Outputs of similar age from Cochrane database of systematic reviews
#45
of 121 outputs
Altmetric has tracked 13,751,259 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,737 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.